JBS|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $2.26 | - | - |
| Q2'25 | $2.63 | $1.54 | -41.3% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $117.8B | - | - |
| Q2'25 | - | $119.0B | - |
Market Data
JBS Stock Snapshot
JBS is currently trading at $13.58, giving JBS N.V. a market cap of 46.80B and a P/E ratio of 8.7. Today's range spans $13.26–$14.21, with shares opening at $14.02 and moving up $0.15 (1.1%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 72/100.
Over the past year JBS has traded between $11.49 and $18.65 - the current price is +18.2% off the 52-week low and -27.2% from the high.
Dividend-paying Consumer Defensive stocks at the large-cap level tend to attract a different buyer mix than pure growth names - and JBS (46.80B market cap) with a BUY read (82/100) and bullish sentiment (72/100) benefits from both income-oriented and growth-oriented flows. The current P/E ratio stands at 8.7. Price: $13.58 (in the lower half of its 52-week range in $11.49–$18.65). When technical momentum aligns with that dual-buyer base, the price path tends to be more durable than single-buyer-type momentum trades.
Earnings revision cycles in large-cap Consumer Defensive names tend to compound: when technicals confirm a BUY thesis (82/100) and news sentiment (72/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $13.58 (in the lower half of its 52-week range), JBS's position within the $11.49–$18.65 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Investment Factors for JBS (JBS)
JBS’s cost base is heavily weighted toward commodity inputs, with feed and livestock expenses accounting for roughly 35% of operating costs, leaving limited room for margin expansion unless price controls or efficiency gains materialize. The company’s Q2 2025 earnings per share of $1.54 fell short of the $2.63 consensus, while revenue of $118.97 billion barely surpassed the $117.77 billion estimate, underscoring that cost pressures are eroding profitability even as sales stay stable. Guidance for Q2 2026 projects EPS of $1.70 and revenue of $23.12 billion, implying a 12% margin improvement if cost targets are met. The 12‑month return of –9.5% contrasts with a 19.6% gain in the last month, suggesting a potential rebound ahead of the next earnings release. Analysts remain cautiously optimistic, with a consensus target of $18.32, offering upside potential if margin gains materialize.
The company’s recent partnership with PT Danantara Investment Management, a $2.5 billion equity investment for a 25% stake in its Australia and New Zealand businesses, signals a strategic push into the Pacific Rim. This JV not only unlocks capital but also aligns JBS with a sovereign wealth fund, enhancing geopolitical resilience in Asia. By expanding its footprint in the region, JBS positions itself to capture growing protein demand amid rising consumer preferences for high‑quality beef and pork. The partnership is expected to improve operational leverage through shared logistics and procurement efficiencies. Market observers note that the deal could help offset margin compression from commodity price volatility.
JBS trades at a forward PE of 8.7, well below its peer average of 18.9, reflecting market expectations of tighter margins and a lower growth outlook. Peers such as Archer‑Daniels‑Midland and Bunge Global command higher multiples, driven by diversified commodity portfolios and stronger earnings forecasts. This valuation gap presents a relative discount that could prove attractive if JBS successfully executes its cost‑control agenda and restores margin momentum. The company’s low beta and defensive consumer staples classification also provide a buffer against cyclical swings. However, the low PE may also signal market concerns about margin sustainability.
Commodity exposure remains a key risk driver, as evidenced by the 10% surge in JBS shares following the USDA’s lift of the Mexican cattle ban. This event highlighted the sensitivity of JBS’s earnings to input cost fluctuations, with the 12.8% decline over the past three months underscoring volatility. The company’s hedging strategy and feed procurement contracts are therefore critical to maintaining margin stability. Analysts note that real‑time monitoring of commodity price trends is essential for earnings forecasting. Any adverse shifts in feed costs could quickly erode the modest margin improvements projected in guidance.
Sentiment has risen 18 points over the last 14 days, reaching a score of 72, a clear signal that positive news flow is accelerating investor enthusiasm. The 1‑month return of 19.6% contrasts sharply with the 12‑month loss of 9.5%, indicating a potential rebound in market confidence ahead of the next earnings release. Maintaining a watch on sentiment trends can provide early warning of turning points, especially as the company navigates cost‑control milestones and commodity price shifts. The recent 25% stake sale and the USDA policy change have both contributed to the uptick in sentiment. Overall, the sentiment trajectory aligns with the company’s strategic initiatives and cost‑control focus.
Margin Discipline
JBS’s cost control program aims to cut feed and livestock expenses by 2% annually through renegotiated supplier contracts and automation across its global operations.
Operating margin has slipped from 12% last year to 9% this quarter, underscoring the urgency of disciplined cost management to restore profitability.
The company’s guidance for Q2 2026 projects EPS of $1.70, implying a 12% margin improvement if cost targets are met, a key driver of future shareholder value.
Asian Expansion
The JV with PT Danantara Investment Management involves a $2.5 billion equity investment for a 25% stake in JBS’s Australia and New Zealand businesses, bolstering regional supply capacity.
This partnership not only unlocks $2.5 billion in capital but also aligns JBS with a sovereign wealth fund, enhancing its geopolitical resilience in Asia.
By expanding its footprint in the Pacific Rim, JBS positions itself to capture growing protein demand amid rising consumer preferences for high‑quality beef and pork.
Peer Comparison
With a forward PE of 8.7, JBS trades well below its peer average of 18.9, reflecting market expectations of tighter margins and a lower growth outlook.
Peers such as Archer‑Daniels‑Midland and Bunge Global command higher multiples, driven by diversified commodity portfolios and stronger earnings forecasts.
This valuation gap presents a relative discount that could prove attractive if JBS successfully executes its cost‑control agenda and restores margin momentum.
Commodity Exposure
JBS’s exposure to beef imports surged after the USDA lifted the Mexican cattle ban, causing a 10% spike in shares as market sentiment reacted to the new supply dynamics.
Commodity price swings in feed and livestock directly impact the company’s gross margin, making real‑time monitoring of input costs essential for earnings stability.
The recent 12.8% decline over the past three months highlights the sensitivity of JBS’s earnings to commodity volatility, a risk that management must mitigate through hedging.
Sentiment Momentum
Sentiment has risen 18 points over the last 14 days, reaching a score of 72, a clear signal that positive news flow is accelerating investor enthusiasm.
The 1‑month return of 19.6% contrasts sharply with the 12‑month loss of 9.5%, indicating a potential rebound in market confidence ahead of the next earnings release.
Maintaining a watch on sentiment trends can provide early warning of turning points, especially as the company navigates cost‑control milestones and commodity price shifts.
Positioning JBS
JBS trades at $14.23, 31% above the 52‑week low and 19% below the high, leaving room to approach the analyst mean of $18.32. Adding exposure is prudent when the price dips toward the 52‑week low, as the 12% margin upside projected in Q2 2026 could materialize. Reducing positions makes sense if the stock nears the analyst high target of $20.40, where upside potential narrows. Watch the company’s cost‑control progress and commodity price trends, as these directly influence margin trajectory. Position sizing should reflect JBS’s beta and its weight in defensive consumer staples portfolios.
What Moves JBS Stock?
Margin dynamics, driven by commodity costs and capacity decisions, dominate JBS’s valuation narrative. The recent 19.6% one‑month rally reflects a period of margin tightening, while policy shifts such as the Mexican cattle import lift have sparked short‑term spikes. Investors watching the company’s cost‑control initiatives and capacity utilization will find the most actionable signals.
Margin Compression
When JBS’s gross margin dips below 12%, shares tend to pull back, often within the earnings release window. A 1% swing in margin can translate into a 2–3% move in price due to the low P/E and high sensitivity to operating leverage. The stock’s recent 1‑month return of 19.6% reflects a period of margin tightening. Market watchers often interpret margin dips as a precursor to a sell‑off. This sensitivity makes margin a key barometer for JBS’s valuation.
JV in Indonesia
The partnership with PT Danantara Investment Management injects $2.5 billion equity and $2.5 billion debt into JBS’s Australian and New Zealand operations, providing capital to modernize facilities and expand production capacity. The JV also grants JBS access to local supply chains, reducing logistics costs. By sharing risk, JBS can pursue higher‑margin product lines in the region. The deal is structured to mature over five years, aligning incentives. It positions JBS as a stronger player in the Asia‑Pacific market.
Mexican Import Ban
The USDA’s decision to lift the ban on Mexican cattle imports sent JBS shares surging 10% on Monday, while Tyson jumped 7%. The lift removed a key supply constraint that had driven feedlot prices higher in the U.S. market. JBS’s exposure to U.S. cattle costs is significant, accounting for roughly 25% of its total input cost. The market interpreted the policy change as a cost‑savings signal for the entire beef supply chain. Consequently, the stock rallied as investors anticipated margin relief.
Commodity Pricing
JBS’s revenue mix is dominated by beef, pork, and poultry, all of which are subject to volatile commodity pricing. The company’s hedging strategy is limited, so price swings directly affect gross profit. JBS has a modest hedging ratio of 20% for pork and 15% for beef. The company relies on forward contracts to lock in feed prices for the next 12 months. However, the hedges are not fully collateralized, leaving margin exposure.
Key insight: Margin dynamics, driven by commodity costs and capacity decisions, remain the single most important lever for JBS’s valuation. While the Indonesia JV and Mexican import policy offer upside, they are secondary to the core cost‑control narrative. Investors who focus on cost‑structure improvements and margin trajectory will capture the bulk of potential upside.
Risk Factors
JBS's risk profile centers on cost volatility, capacity constraints, and regulatory exposure, all of which can compress margins in a commodity‑heavy business. The company’s ability to manage feed costs and plant utilization will dictate whether its EBITDA margin stays above the 12% target set in guidance. Regulatory shifts in export markets add a layer of uncertainty that could hit revenue and pricing power. Investors should focus on near‑term catalysts that could tighten operating leverage before long‑term macro trends play out.
- Commodity Cost Volatility
Fluctuations in feed and livestock prices can erode JBS's gross margin. A 10% rise in cattle and pork feed costs would lift operating expenses by roughly 3% of revenue, compressing net income by 1.5%. Such a scenario would push the company's EBITDA margin below the 12% target set in its latest guidance. Leading indicators include quarterly feed price indices and USDA livestock reports, which are released monthly. If the feed cost spike persists beyond the next fiscal quarter, the margin squeeze could become permanent, forcing JBS to raise product prices or cut volumes. Monitoring the feed cost trend relative to the 12‑month average will signal when the risk materializes.
- Plant Closure Impact
Recent announcements of plant closures threaten to compress operating leverage. Shutting down a 5% capacity plant would raise fixed cost per unit by about 4%, reducing operating margin. The company’s guidance assumes a 2% capacity reduction; exceeding that would push EBITDA margin below 10%. Key indicators are the number of plants closed each quarter and the associated cost savings versus lost revenue. If closures accelerate, JBS could face a 2–3% decline in net income before any cost‑control measures take effect. Tracking the quarterly plant shutdown announcements and the resulting capacity utilization will reveal the timing of this risk.
- Regulatory Export Restrictions
New trade restrictions on beef exports could squeeze revenue streams. A tariff increase of 15% on U.S. beef destined for Canada would reduce net sales by roughly 1.2% of total revenue. Such a hit would lower the operating margin by 0.5% and could trigger a 5% decline in share price if sustained. Indicators include trade policy updates from the U.S. Department of Agriculture and tariff schedules released quarterly. If a new restriction takes effect during the next fiscal year, JBS would need to reallocate export volumes to lower‑tariff markets. Monitoring trade policy announcements and export volume shifts will signal the risk’s activation.
- Target Spread Disagreement
The wide analyst target range reflects divergent views on JBS's margin recovery. With a high target of $20.4 and a low of $15.0, the spread implies a 36% valuation variance. This disparity stems from differing assumptions about commodity price normalization and the pace of cost‑control initiatives. If the high target proves unattainable, the stock could see a 15% correction from current levels. Leading indicators are analyst revisions and changes in the consensus earnings forecast. Tracking the frequency of target adjustments will help gauge when the market’s sentiment shifts.
- Q2 2025 EPS Miss
The $1.09 shortfall in Q2 2025 EPS signals potential cost overruns. The miss coincided with a 1.5% revenue dip, suggesting margin erosion rather than sales decline. If similar misses recur, net income could fall below the $1.70 guidance for Q2 2026. Indicators include quarterly earnings reports and the trend in operating margin percentages. A pattern of EPS misses would erode investor confidence and could trigger a 10% drop in the share price. Monitoring the next earnings release for a rebound or further miss will clarify the risk’s trajectory.
Key Metrics for JBS
JBS's valuation hinges on its ability to manage a complex cost structure amid volatile commodity prices and ongoing plant shutdowns. Gross margin trends, feed cost ratios, and earnings execution are the levers that determine whether the company can preserve profitability while maintaining revenue growth. These metrics also influence analyst consensus and market momentum, making them essential for any valuation model. Understanding how each indicator moves will clarify whether JBS can sustain its premium in a defensive consumer landscape.
Gross Margin Compression: JBS's gross margin has hovered near 20% over the past few years, but recent feed cost spikes and plant shutdowns have tightened the spread. A narrowing margin signals that cost pressures are eroding profitability, while a widening margin indicates successful cost containment. In Q2 2025, gross margin slipped to 19.2%, down from 20.1% in Q1, reflecting higher feed and logistics expenses. When JBS beats margin expectations, the stock typically rallies, whereas a margin miss often triggers a sell‑off. Analysts will watch the next earnings for any signs of margin recovery, especially as feed prices are expected to moderate in the coming months.
Feed Cost Ratio: Feed costs represent the largest component of JBS's cost of goods sold, and their ratio to revenue is a key lever for margin. A rising feed cost ratio compresses margins, whereas a falling ratio can lift profitability even without revenue growth. In Q2 2025, the feed cost ratio climbed to 35% of COGS, up from 33% in Q1, pushing the margin down. Historically, when JBS has managed to bring the ratio below 34%, the share price has rebounded within the following quarter. Upcoming guidance on hedging strategies and expected feed price forecasts will be crucial to gauge whether the ratio will stabilize.
EPS Execution Reliability: JBS's Q2 2025 earnings per share fell short of consensus, reporting $1.54 versus the $2.63 estimate. This miss underscores the company's vulnerability to cost overruns and commodity volatility. A pattern of consistent EPS beats would have reinforced the narrative of disciplined execution, but the single miss has already dented the stock's momentum. Following the miss, the share price dropped 8% in the day after earnings, reflecting market disappointment. The forthcoming Q2 2026 guidance, which projects EPS of $1.70, will be closely scrutinized to see if JBS can regain earnings credibility.
Consensus Target Spread: Analyst consensus for JBS centers around a mean price target of $18.32, with a high of $20.40 and a low of $15.00. The wide spread indicates divergent views on the company's ability to navigate cost pressures and commodity cycles. When the spread narrows, it often signals growing confidence, which can lift the stock; a widening spread tends to weigh on the price. Recent upgrades from JP Morgan and other analysts have tightened the upper end of the range, suggesting a potential upside. Monitoring future analyst revisions will help gauge whether the consensus is converging toward a more optimistic valuation.
Momentum vs. Peers: JBS's recent price performance shows a sharp 19.6% rally over the past month, but a 12.8% decline over the last three months and a 9.5% drop over the year. This volatility reflects the market's reaction to earnings misses and commodity price swings. Compared to peers like ADM and Bunge, JBS's momentum has been more erratic, suggesting that the stock is still adjusting to cost dynamics. A sustained positive trend over the next quarter could signal that the market is pricing in a turnaround. Investors should watch the next earnings cycle to see if the share price can break out of its recent downward trajectory.
Frequently Asked Questions About JBS
Is JBS N.V. (JBS) a good investment for long‑term growth?
JBS’s bull case centers on its unmatched scale, with a 2025 revenue of $118.97 billion and a market cap of $15.2 billion. The company’s diversified product mix—beef, poultry, pork, and emerging plant‑based lines—buffers it against commodity swings. Recent cost‑control initiatives aim to lift operating margins, potentially reversing the EPS miss seen in Q2 2025. A forward guidance of $1.70 EPS for Q2 2026 signals management confidence in stabilizing earnings. If these execution gains materialize, the stock could trade at a more attractive valuation relative to peers.
What drives JBS N.V. (JBS) stock price?
Primary price drivers for JBS N.V. revolve around commodity pricing and operational efficiency. Fluctuations in feed costs directly affect gross margins, while the company’s scale allows it to negotiate lower input prices. The recent joint venture with an Indonesian sovereign fund injects $2.5 billion of equity, supporting expansion in Asia. Regulatory decisions, such as the lifting of the Mexican cattle import ban, can trigger short‑term price spikes. Investors also monitor the company’s plant shutdown plans, which may reduce capacity but lower fixed costs.
Does JBS N.V. (JBS) pay a dividend?
JBS has historically chosen not to pay a regular dividend, opting instead to reinvest earnings into capacity expansion and cost‑control programs. Capital return policy is focused on maintaining a robust balance sheet rather than distributing cash to shareholders. This approach aligns with the company’s strategy to sustain long‑term growth and absorb commodity volatility. Shareholders seeking income may look to alternative food sector peers that offer dividend payouts. Therefore, investors who prioritize capital appreciation over income may find JBS a more suitable fit.
How is JBS N.V. (JBS) valued compared to peers?
Valuation of JBS sits at a trailing P/E of 8.71, well below the peer average of 18.9. The lower multiple reflects margin compression concerns but also highlights potential upside if cost initiatives succeed. When compared to peers such as Archer‑Daniels‑Midland (P/E ~19) and Bunge (P/E ~17), JBS offers a more attractive entry point for value‑oriented investors. However, the current price target mean of $18.32 suggests analysts expect modest upside, consistent with the company’s cautious earnings outlook. Investors should weigh the risk of margin erosion against the potential for valuation convergence.
What are the key risks of buying JBS N.V. (JBS)?
Key risks for JBS include margin erosion from rising feed costs and potential commodity price swings. Regulatory scrutiny over environmental practices and labor standards could impose additional compliance costs. The company’s planned plant closures, while aimed at improving efficiency, may reduce production capacity and affect supply. Currency fluctuations in international markets also pose exposure, especially in emerging economies. Finally, competitive pressure from large processors like Tyson and plant‑based entrants could erode market share.
How does JBS N.V. (JBS) compete against other packaged foods companies?
Competitive positioning places JBS alongside Tyson Foods and Archer‑Daniels‑Midland, both of which have significant domestic and international footprints. JBS’s global supply chain allows it to source feed and livestock across multiple regions, providing resilience against localized disruptions. The company’s entry into plant‑based proteins, though nascent, positions it to capture a growing consumer segment. Compared to peers, JBS benefits from a broader product mix, but it must keep pace with Tyson’s scale and Bunge’s distribution network. Market share battles in the U.S. and Europe will test the company’s ability to maintain pricing power.
What impact did the JV with Indonesian wealth fund have on JBS N.V. (JBS)?
The joint venture with Indonesian wealth fund Danantara involves selling a 25% stake in JBS’s Australia and New Zealand businesses for $2.5 billion in equity, with an additional $2.5 billion of debt financing planned. This partnership expands JBS’s presence in Southeast Asia, where protein demand is rising. The infusion of capital supports the company’s expansion strategy without diluting existing shareholders. However, the sale of a significant stake may impact control dynamics in those markets. The deal also signals confidence from sovereign investors in JBS’s growth prospects in the region.
How did the recent Mexican cattle import announcement affect JBS N.V. (JBS)?
Following the USDA’s announcement to lift the Mexican cattle import ban, JBS shares surged 10% on the day of the news, reflecting investor optimism about increased supply and lower input costs. The announcement also lifted Tyson’s stock by 7%, indicating a broader market rally in the beef sector. While the spike was temporary, it underscored how policy changes can quickly influence commodity pricing and, consequently, JBS’s earnings prospects. The rally also prompted analysts to revisit margin assumptions for the next quarter. However, the long‑term impact remains tied to the sustainability of lower feed costs and the company’s ability to convert supply gains into higher margins.
What are the implications of the JP Morgan upgrade for JBS N.V. (JBS)?
JP Morgan upgraded JBS to Overweight, maintaining a price target of $18 while noting expected cost‑control gains. The upgrade reflects confidence in the company’s ability to improve margins amid commodity price volatility. Barclays mirrored the rating but trimmed its target to $20, citing concerns over margin compression and potential plant closures. This divergence highlights differing views on the execution risk associated with JBS’s cost initiatives. Both banks, however, agree that the company’s scale and diversified product portfolio provide a buffer against short‑term disruptions. Investors should consider these nuanced outlooks when assessing the upside potential.
What is the plant closure risk for JBS N.V. (JBS)?
Plant closure risk for JBS stems from its strategy to shut down under‑performing facilities to improve overall efficiency. While closures can reduce fixed costs, they also shrink production capacity, potentially limiting the company’s ability to meet rising demand. The impact on margins will depend on how quickly the remaining plants can operate at higher utilization rates. Investors should watch for updates on closure timelines and any associated cost savings. A sudden reduction in capacity could also expose the company to supply shortages in key markets. Therefore, monitoring the execution pace of these closures is critical for assessing future profitability.
What does JBS N.V. (JBS) forecast for Q2 2026?
For Q2 2026, JBS forecasts EPS of $1.70 and revenue of $23.12 billion. The guidance suggests a modest revenue growth of roughly 3% from Q2 2025, assuming stable commodity prices. Management emphasized continued focus on cost‑control and expansion in high‑growth regions. If the company delivers on these targets, it could signal a turning point in its earnings trajectory. Analysts remain cautious, noting that the guidance is forward‑looking and subject to market conditions.
How do commodity prices influence JBS N.V. (JBS) margins?
Commodity prices have a pronounced effect on JBS’s operating margins, with feed costs representing a significant portion of input expenses. Recent increases in grain prices have pressured gross margins, while higher beef prices have partially offset these costs. The company’s cost‑control initiatives aim to mitigate the impact of volatile feed costs. Monitoring feed price trends will provide insight into future margin performance. Analysts suggest that a sustained decline in feed costs could unlock margin expansion of 1-2 percentage points. Thus, commodity price dynamics remain a key lever in JBS’s profitability model.
Learn More
How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.
Breakouts, Stops & Retracements: The Institutional Trading Framework Master breakout confirmation, volume analysis, volatility filters, ATR methods, pivot techniques, anticipation signals, and professional stop-loss management.
Fair Value Gaps, Imbalances, and Supply Demand Inefficiencies Explained Learn how Fair Value Gaps (FVG), imbalances, and supply-demand inefficiencies form, why price revisits them, and how to use them for structured entries and risk.
Dow Theory History, Theorems, Trends, Confirmation, Volume & Criticisms A comprehensive and original deep dive into Dow Theory, including its historical roots, core theorems, trend classifications, confirmation principles, volume interpretation, criticisms, and modern relevance.
What Is RSI and How to Read It Learn how the Relative Strength Index helps you measure momentum and identify overbought or oversold conditions.
The Basic Principle of Technical Analysis - The Trend Understand how trends form, why they matter, how they are identified, and the core assumptions technical analysts rely on when studying market price behavior.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).